Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coccidioidomycosis.

Gregory M Anstead1, John R Graybill

  • 1Department of Medicine, Division of Infectious Diseases, University of Texas Health Science Center at San Antonio, TX 78229, USA. anstead@uthscsa.edu

Infectious Disease Clinics of North America
|September 21, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Meningoencephalitis in Flea-Borne Typhus: A Report of Two Cases and a Review of CNS Complications.

Pathogens (Basel, Switzerland)·2026
Same author

Pulmonary Alveolar Proteinosis in a Patient with Severe Flea-Borne Typhus.

The American journal of tropical medicine and hygiene·2026
Same author

A One Health Perspective on the Resurgence of Flea-Borne Typhus in Texas in the 21st Century: Part 1: The Bacteria, the Cat Flea, Urbanization, and Climate Change.

Pathogens (Basel, Switzerland)·2025
Same author

The Maturation of the International Health Crisis Response: The Polish Typhus Epidemic of 1916-1923 Compared to the African Ebola Virus Disease Epidemic of 2013-2016: Part I, the Polish Epidemic.

Epidemiologia (Basel, Switzerland)·2024
Same author

<i>Capnocytophaga canimorsus</i> Endocarditis Presenting with Leukocytoclastic Vasculitis and Glomerulonephritis.

Microorganisms·2024
Same author

An Exuberant Case of Ulceronodular-Rupioid (Malignant) Syphilis in an HIV Patient: A Proposal for New Diagnostic Criteria.

Infectious disease reports·2024
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Managing coccidioidomycosis is challenging due to host factors impacting outcomes. New azole therapies show promise, but further clinical trials are essential for improved treatment of this fungal infection.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Coccidioidomycosis presents significant management challenges due to diverse manifestations and host factor influence.
  • Despite therapeutic advancements, patient outcomes for coccidioidomycosis remain suboptimal, with continued suffering and mortality.
  • Geographic spread and increased susceptible populations in the southwestern US heighten the risk of coccidioidomycosis infection.

Purpose of the Study:

  • To evaluate the efficacy of extended-spectrum azoles in treating coccidioidomycosis.
  • To compare novel azole therapies with existing treatments like amphotericin B and fluconazole.
  • To highlight the need for further research and clinical trials in coccidioidomycosis management.

Main Methods:

  • Review of existing therapeutic outcomes for coccidioidomycosis.

Related Experiment Videos

  • Comparison of efficacy data for various antifungal agents.
  • Identification of gaps in current treatment protocols and research.

    • Main Results:

    • Extended-spectrum azoles (posaconazole, voriconazole) demonstrate potential for greater efficacy than older agents.
    • While new therapies offer improvements, significant patient suffering and treatment failures persist.
    • Existing treatments like amphotericin B, fluconazole, and itraconazole have limitations in managing severe cases.

    Conclusions:

    • Extended-spectrum azoles represent a promising therapeutic option for coccidioidomycosis.
    • Continued research and robust clinical trials are crucial for optimizing coccidioidomycosis treatment strategies.
    • Addressing the complexities of host factors and disease management requires ongoing investigation and resource allocation.